Abstract

http://ssrn.com/abstract=512002
 
 

Footnotes (238)



 


 



Therapeutic Orphans, Pediatric Victims? The Best Pharmaceuticals for Children Act and Existing Pediatric Human Subject Protection


I. Glenn Cohen


Harvard Law School


Food and Drug Law Journal, Vol. 58, No. 4, pp. 661-710, 2003

Abstract:     
In 2002 the President signed into law the Best Pharmaceuticals for Children Act, which gives incentives for research on a group that has previously been considered therapeutic orphans when it comes to drug safety and dosage testing: Children. The Act offers an extra 6 months of market exclusivity for a drug if the manufacturer conducts drug trials in pediatric populations meeting FDA's requirements. While the intent of Congress with this act was to make drugs safer for children, it is an open question whether this is being achieved at the expense of pediatric research subjects, and the threat of a race to the bottom in research ethics looms large.

This Article describes the Act, its origins, and existing federal regulations protecting children as research subjects, while reviewing the history of pediatric research and the bioethical dilemmas it poses. The Article then discusses shortcomings in the existing scheme and describes necessary changes to better protect the welfare of children in the research setting.

Number of Pages in PDF File: 51

Keywords: Food, drug, FDA, pediatrics, children, family law, health law, bioethics, IRB, research, human subjects, administrative law, market exclusivity, patent, informed consent

JEL Classification: H5, I10, I1, I18, K00, K13, K23, K32

Accepted Paper Series


Download This Paper

Date posted: March 5, 2004 ; Last revised: June 2, 2013

Suggested Citation

Cohen, I. Glenn, Therapeutic Orphans, Pediatric Victims? The Best Pharmaceuticals for Children Act and Existing Pediatric Human Subject Protection. Food and Drug Law Journal, Vol. 58, No. 4, pp. 661-710, 2003. Available at SSRN: http://ssrn.com/abstract=512002

Contact Information

I. Glenn Cohen (Contact Author)
Harvard Law School ( email )
1525 Massachusetts Avenue
Griswold Hall 503
Cambridge, 02138
United States
Feedback to SSRN


Paper statistics
Abstract Views: 2,336
Downloads: 208
Download Rank: 83,530
Footnotes:  238

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo7 in 0.218 seconds